Impact of Conjugate Pneumococcal Vaccines

From the Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention Atlanta, GA Sponsored by MedImmune, Inc. CONTENTS Impact of Conjugate Pneumococcal Vaccines EDITORIAL BOARD Co-Editors:Margaret C. Fisher, MD and Gary D. Overturf, MD Editor for this Issue:Katherine O'Brien, MD, MPH Board Members Michael Cappello, MD Ellen G. Chadwick, MD Toni Darville, MD Kathleen McGann, MD Leonard R. Krilov, MD Charles T. Leach, MD H. Cody Meissner, MD Katherine O'Brien, MD, MPH John R. Schreiber, MD, MPH Jeffrey R. Starke, MD Geoffrey A. Weinberg, MD Charles Wood, MD